Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seminoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Medulloblastoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hearing Loss 1Carcinoma 1

Interventions

Cisplatin 18Magnetic Resonance Spectroscopy 11Specimen Handling 9Radiotherapy, Intensity-Modulated 7Radiotherapy 7Radiation 7Carboplatin 7Platinum 5Chemoradiotherapy 51,2-diaminocyclohexaneplatinum II citrate 5Surgical Procedures, Operative 4Paclitaxel 4Docetaxel 4Biopsy 4pembrolizumab 3Surveys and Questionnaires 3toripalimab 2aldesleukin 2X-Rays 2Taxes 2Observation 2Interviews as Topic 2Immunohistochemistry 2Cetuximab 2Adoptive Transfer 2sacituzumab govitecan 1merphos 1ipatasertib 1human papillomavirus vaccine, TA 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Oropharyngeal Neoplasms × Hearing × Clear all
NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡